Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2012
08/14/2012US8241655 Coatings for medical articles including natural biodegradable polysaccharides
08/14/2012US8241646 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
08/14/2012US8241645 Vaccine
08/14/2012US8241644 In vitro model of latent mycobacterial infection
08/14/2012US8241643 Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto
08/14/2012US8241642 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
08/14/2012US8241641 Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
08/14/2012US8241640 Pharmaceutical botulinum toxin compositions
08/14/2012US8241639 Extracellular domains of Epstein Barr Virus (EBV) tumor-associated latent membrane proteins
08/14/2012US8241638 Induction of an immune response against dengue virus using the prime-boost approach
08/14/2012US8241637 DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof
08/14/2012US8241636 Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
08/14/2012US8241633 Anti-FGF19 antibodies and methods using same
08/14/2012US8241632 Stable polypeptide formulations
08/14/2012US8241631 Human binding molecules having killing activity against enterococci and uses thereof
08/14/2012US8241630 HER2 antibody composition
08/14/2012US8241629 Anti-human IL-21 monoclonal antibodies
08/14/2012US8241628 Compositions and methods for antibodies targeting complement protein C5
08/14/2012US8241627 Modified polypeptides stabilized in a desired conformation and methods for producing same
08/14/2012US8241626 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/14/2012US8241625 Medicament and a method for regulation of the vascular tone
08/14/2012US8241610 Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines
08/14/2012US8241608 Treating allergy with detoxified E. coli heat-labile enterotoxin
08/14/2012CA2530625C Antigen-containing microspheres for allergy therapy
08/14/2012CA2522747C Method of detecting native probnp with a monoclonal antibody binding to the amino acids 38-43
08/14/2012CA2501821C Bispecific anti-erb-b antibodies and their use in tumor therapy
08/14/2012CA2486345C Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
08/14/2012CA2457485C Combination motif immune stimulatory oligonucleotides with improved activity
08/14/2012CA2452075C Sustained release delivery system
08/14/2012CA2436326C Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
08/14/2012CA2407905C Antibodies capable to selectively detect prion prpsc isoforms
08/14/2012CA2373274C Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/14/2012CA2332455C Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
08/14/2012CA2218166C Methods of inducing immune tolerance using immunotoxins
08/09/2012WO2012106670A2 Expandable liquid volume in an led bulb
08/09/2012WO2012106669A2 Foxc1 antibodies and methods of their use
08/09/2012WO2012106634A1 Use of an anti-cd200 antibody for prolonging the survival of allografts
08/09/2012WO2012106578A1 HIV NEUTRALIZING ANTIBODIES HAVING MUTATIONS IN CONSTANT DOMAIN (Fc)
08/09/2012WO2012106497A2 Selection and treatment of subjects
08/09/2012WO2012106490A1 Multivalent vaccines for rabies virus and filoviruses
08/09/2012WO2012106473A2 Dosing for treatment with anti-egfl7 antibodies
08/09/2012WO2012106368A2 Methods for inhibiting prostate cancer
08/09/2012WO2012106363A2 Treatment of tauopathies
08/09/2012WO2012106313A2 Ubiquitin interacting motif peptides as cancer therapeutics
08/09/2012WO2012106251A2 Pertussis vaccine
08/09/2012WO2012106231A2 Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza a viruses
08/09/2012WO2012106192A1 Antibody specific for sulfatase-2 and methods of use thereof
08/09/2012WO2012105541A1 Novel japanese cypress pollen allergen
08/09/2012WO2012105532A1 Novel use of maltotriosyl transferase
08/09/2012WO2012105224A1 Vaccine adjuvant
08/09/2012WO2012105219A1 Antibody therapy effect-enhancing drug
08/09/2012WO2012104821A1 Immunogenic bordetella bronchiseptica compositions
08/09/2012WO2012104820A1 Compositions for canine respiratory disease complex
08/09/2012WO2012104581A1 Anti-tace antibody molecules and their uses
08/09/2012WO2012104411A1 Lipoproteins labelling, methods for tracking transport/outcome of lipoproteins and for determining dyslipidemia disorders
08/09/2012WO2012103787A1 Use of anti-dkk1 monoclonal antibody for treatment of liver cancer
08/09/2012WO2012082841A9 Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer
08/09/2012WO2012080985A3 Insecticide cry proteins of bacillus thuringiensis with anti-cancer activity
08/09/2012WO2012079878A3 Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
08/09/2012WO2012076670A3 Antibody formulation
08/09/2012WO2012075342A3 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
08/09/2012WO2012075147A3 Stable helical ionic polypeptides
08/09/2012WO2012068332A9 Methods for treating early stage or mild neurological disorders
08/09/2012WO2012068073A3 Therapeutic and diagnostic applications targeting tnk-1
08/09/2012WO2012047265A3 Improved adjuvant system for vaccine administration
08/09/2012WO2012016073A3 Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions
08/09/2012WO2011163452A8 Treating surface of the eye disorders
08/09/2012WO2011133559A3 Alpha tubulin acetyltransferase
08/09/2012WO2011115684A3 Lipid vesicle compositions and methods of use
08/09/2012WO2011088120A9 Antibody formulation and therapeutic regimens
08/09/2012WO2011083091A8 Methods for treating pancreatic cancer
08/09/2012US20120204275 Apoe immunotherapy
08/09/2012US20120202208 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
08/09/2012US20120202206 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
08/09/2012US20120201892 Porous-wall hollow glass microspheres as carriers for biomolecules
08/09/2012US20120201857 Transdermal delivery system for therapeutics
08/09/2012US20120201853 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins
08/09/2012US20120201852 Vaccines Against Japanese Encephalitis Virus and West Nile Virus
08/09/2012US20120201851 Generic assay for detection of influenza viruses
08/09/2012US20120201850 Infectious bovine viral diarrhea virus
08/09/2012US20120201849 Vaccine stabilizer
08/09/2012US20120201848 Isolation of a virus related to canine parvovirus-2 from a raccoon
08/09/2012US20120201847 Vaccine Formulations and Uses Thereof
08/09/2012US20120201846 Polymer particles and uses thereof
08/09/2012US20120201845 Transcutaneous immunization without heterologous adjuvant
08/09/2012US20120201844 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/09/2012US20120201843 Cyp1b1 nucleic acids and methods of use
08/09/2012US20120201842 Prevention and treatment of synucleinopathic and amyloidogenic disease
08/09/2012US20120201841 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
08/09/2012US20120201840 EphA2 T-Cell Epitopes and Uses Therefor
08/09/2012US20120201839 Allergy treatment using acid treated aqueous whey protein extract
08/09/2012US20120201838 Method for screening anticancer agent or sip1/zeb2 inhibitor using integrin alpha 5
08/09/2012US20120201837 Use of eif3m for the diagnosis and treatment of cancer
08/09/2012US20120201836 Methods and compositions for modulating t cell and/or b cell activation
08/09/2012US20120201835 Antibodies specific for dkk-1
08/09/2012US20120201834 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
08/09/2012US20120201833 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
08/09/2012US20120201832 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201830 Compositions and methods for treating macular edema
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 1823